Evidence map›Paper›PMID 27387239›Full record

ArticleBiochemical and biophysical research communications2016

Silver adducts of four-branched histidine rich peptides exhibit synergistic antifungal activity.

Qixin Leng, Martin C Woodle, Yijia Liu, A James Mixson

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Qixin LengDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Martin C WoodleAparna Biosciences Corp, Rockville, MD 20852, USA.
Yijia LiuAparna Biosciences Corp, Rockville, MD 20852, USA.
A James MixsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: Jmixson@som.umaryland.edu.
AparnaBio (United States) · USUniversity of Maryland, Baltimore · US

Funding

Ident. of Structural Features of HK Polyplexes for Imprv. siRNA Deliv. to TumorsR01CA136938 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MIXSON, ARCHIBALD JAMES · 2009 to 2012
$1.2M
NCI NIH HHS R01 CA136938
6 · The paper itself

Abstract

Previously, a four branched histidine-lysine rich peptide, H3K4b, was shown to demonstrate selective antifungal activity with minimal antibacterial activity. Due to the potential breakdown from proteases, H3K4b was further evaluated in the current study by varying the D- and l-amino acid content in its branches. Whereas analogues of H3K4b that selectively replaced l-amino acids (H3k4b, h3K4b) had improved antifungal activity, the all d-amino acid analogue, h3k4b, had reduced activity, suggesting that partial breakdown of the peptide may be necessary. Moreover, because histidines form coordination bonds with the silver ion, we examined whether silver adducts can be formed with these branched histidine-lysine peptides, which may improve antifungal activity. For Candida albicans, the silver adduct of h3K4b or H3k4b reduced the MIC compared to peptide and silver ions alone by 4- and 5-fold, respectively. For Aspergillus fumigatus, the silver adducts showed even greater enhancement of activity. Although the silver adducts of H3k4b or h3K4b showed synergistic activity, the silver adduct with the all l-amino acid H3K4b surprisingly showed the greatest synergistic and growth inhibition of A. fumigatus: the silver adduct of H3K4b reduced the MIC compared to the peptide and silver ions alone by 30- and 26-fold, respectively. Consistent with these antifungal efficacy results, marked increases in free oxygen radicals were produced with the H3K4b and silver combination. These studies suggest that there is a balance between stability and breakdown for optimal antifungal activity of the peptide alone and for the peptide-silver adduct.

Indexed as

Antifungal AgentsApoptosisAspergillus fumigatusCell SurvivalDose-Response Relationship, DrugDrug DesignDrug SynergismHistidinePeptidesSilverAntifungal AgentsHistidinePeptidesSilverAntimicrobial peptidesAspergillusCandidaSilverTherapy

Identifiers

PMID27387239
PMCPMC4968200
OpenAlexW2460607470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.